SEC Form 4 · accession 0001415889-15-000129
Vistagen Therapeutics, Inc. · VTGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
H. Ralph Snodgrass
Officer — PRES./CHIEF SCIENTIFIC OFFICER · Director
Period of report
Jan 11, 2015
Accepted (ET)
Jan 13, 2015 · 5:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411685
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant for Common Stock | $10.00 | Jan 11, 2015 | A | 100,000 | A | Jan 11, 2015 | Jan 11, 2020 | Common Stock | 100,000 | 100,000 | D |